22 May 2013
Keywords: ec, clears, celgene, revlimid, mm, drugmaker, lenalidomide
Article | 25 June 2007
US drugmaker Celgene's Revlimid (lenalidomide) has been granted full marketing authorization by the European Commission for use in
combination with ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
25 June 2007
21 May 2013
© 2013 thepharmaletter.com